





Many drivers of progression, such as inflammation, metabolic dysfunction, gut permeability, immune dysregulation, are modifiable. While [Condition Name]’s diagnoses may remain, stability and function often improve when root mechanisms are addressed.
Initial symptoms for [Condition Name] shifts often occur within 4-6 weeks. Structural stabilisation typically requires 3-6 months depending on severity and compliance.
Absolutely not! Therapeutic phases for [Condition Name] are temporary. The goal is metabolic flexibility and sustainable diversity.
Yes! ALIVE complements neurologists, rheumatologists, dermatologists, and primary physicians. We do not replace medical supervision.
Conventional care manages progression. ALIVE targets drivers, such as, cellular energy, immune regulation, inflammatory load, nervous system stress, and metabolic resilience.